[Biotherapies for psoriasis: Options following the suspension of Raptiva?]

Ann Dermatol Venereol. 2009 May;136(5):399-401. doi: 10.1016/j.annder.2009.04.009.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens / therapeutic use
  • Humans
  • Psoriasis / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • CD11 Antigens
  • efalizumab